Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Zanchi

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Diabetes Research and Clinical Practice|December 19, 2012
Blockade of the renin-angiotensin system and renal tissue oxygenation as measured with BOLD-MRI in patients with type 2 diabetesMenno Pruijm, Lucie Hofmann, Anne Zanchi, et al.
Frontiers in Pharmacology|February 8, 2024
The differential impact of a 6-<i>versus</i> 12-month pharmacist-led interprofessional medication adherence program on medication adherence in patients with diabetic kidney disease: the randomized PANDIA-IRIS studyCarole Bandiera, Jennifer Dotta-Celio, Isabella Locatelli, et al.
Circulation|November 20, 2002
Poly(ADP-Ribose) polymerase is activated in subjects at risk of developing type 2 diabetes and is associated with impaired vascular reactivityCsaba Szabó, Anne Zanchi, Katalin Komjáti, et al.
Journal of the American Heart Association|June 23, 2020
Acute and Chronic Effects of SGLT2 Inhibitor Empagliflozin on Renal Oxygenation and Blood Pressure Control in Nondiabetic Normotensive Subjects: A Randomized, Placebo-Controlled TrialAnne Zanchi, Michel Burnier, Marie-Eve Muller, et al.
JMIR Research Protocols|March 19, 2021
Interprofessional Medication Adherence Program for Patients With Diabetic Kidney Disease: Protocol for a Randomized Controlled and Qualitative Study (PANDIA-IRIS)Carole Bandiera, Jennifer Dotta-Celio, Isabella Locatelli, et al.
Journal of Clinical Medicine|June 2, 2021
SGLT2 Inhibitors, What the Emergency Physician Needs to Know: A Narrative ReviewHenri Lu, Hortense Lu, Christophe Kosinski, et al.
Frontiers in Medicine|May 15, 2024
Enhancing fetal outcomes in GCK-MODY pregnancies: a precision medicine approach via non-invasive prenatal <i>GCK</i> mutation detectionValérie M Schwitzgebel, Jean-Louis Blouin, Barbara Dehos, et al.
Plos One|October 21, 2014
Pioglitazone improves fat distribution, the adipokine profile and hepatic insulin sensitivity in non-diabetic end-stage renal disease subjects on maintenance dialysis: a randomized cross-over pilot studyAnne Zanchi, Luc Tappy, Kim-Anne Lê, et al.
Swiss Medical Weekly|July 12, 2017
Changing trends in end-stage renal disease patients with diabetesYimin Lu, Christina Stamm, Dina Nobre, et al.
Patient Preference and Adherence|September 1, 2022
Medication Adherence Evaluated Through Electronic Monitors During the 2020 COVID-19 Pandemic Lockdown in Switzerland: A Longitudinal AnalysisCarole Bandiera, Jérôme Pasquier, Isabella Locatelli, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Diabetes Research and Clinical Practice|December 19, 2012
Blockade of the renin-angiotensin system and renal tissue oxygenation as measured with BOLD-MRI in patients with type 2 diabetesMenno Pruijm, Lucie Hofmann, Anne Zanchi, et al.
Frontiers in Pharmacology|February 8, 2024
The differential impact of a 6-<i>versus</i> 12-month pharmacist-led interprofessional medication adherence program on medication adherence in patients with diabetic kidney disease: the randomized PANDIA-IRIS studyCarole Bandiera, Jennifer Dotta-Celio, Isabella Locatelli, et al.
Circulation|November 20, 2002
Poly(ADP-Ribose) polymerase is activated in subjects at risk of developing type 2 diabetes and is associated with impaired vascular reactivityCsaba Szabó, Anne Zanchi, Katalin Komjáti, et al.
Journal of the American Heart Association|June 23, 2020
Acute and Chronic Effects of SGLT2 Inhibitor Empagliflozin on Renal Oxygenation and Blood Pressure Control in Nondiabetic Normotensive Subjects: A Randomized, Placebo-Controlled TrialAnne Zanchi, Michel Burnier, Marie-Eve Muller, et al.
JMIR Research Protocols|March 19, 2021
Interprofessional Medication Adherence Program for Patients With Diabetic Kidney Disease: Protocol for a Randomized Controlled and Qualitative Study (PANDIA-IRIS)Carole Bandiera, Jennifer Dotta-Celio, Isabella Locatelli, et al.
Journal of Clinical Medicine|June 2, 2021
SGLT2 Inhibitors, What the Emergency Physician Needs to Know: A Narrative ReviewHenri Lu, Hortense Lu, Christophe Kosinski, et al.
Frontiers in Medicine|May 15, 2024
Enhancing fetal outcomes in GCK-MODY pregnancies: a precision medicine approach via non-invasive prenatal <i>GCK</i> mutation detectionValérie M Schwitzgebel, Jean-Louis Blouin, Barbara Dehos, et al.
Plos One|October 21, 2014
Pioglitazone improves fat distribution, the adipokine profile and hepatic insulin sensitivity in non-diabetic end-stage renal disease subjects on maintenance dialysis: a randomized cross-over pilot studyAnne Zanchi, Luc Tappy, Kim-Anne Lê, et al.
Swiss Medical Weekly|July 12, 2017
Changing trends in end-stage renal disease patients with diabetesYimin Lu, Christina Stamm, Dina Nobre, et al.
Patient Preference and Adherence|September 1, 2022
Medication Adherence Evaluated Through Electronic Monitors During the 2020 COVID-19 Pandemic Lockdown in Switzerland: A Longitudinal AnalysisCarole Bandiera, Jérôme Pasquier, Isabella Locatelli, et al.
Pageof 5